Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Tools to Measure Cell Health and Cytotoxicity Using High Content Imaging and Analysis.

Mandavilli BS, Aggeler RJ, Chambers KM.

Methods Mol Biol. 2018;1683:33-46. doi: 10.1007/978-1-4939-7357-6_3. Review.

PMID:
29082485
2.

Water-soluble poly(2,7-dibenzosilole) as an ultra-bright fluorescent label for antibody-based flow cytometry.

Wang X, Hu YZ, Chen A, Wu Y, Aggeler R, Low Q, Kang HC, Gee KR.

Chem Commun (Camb). 2016 Mar 14;52(21):4022-4. doi: 10.1039/c5cc10347a.

PMID:
26888307
3.

Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.

Houghton JL, Zeglis BM, Abdel-Atti D, Aggeler R, Sawada R, Agnew BJ, Scholz WW, Lewis JS.

Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15850-5. doi: 10.1073/pnas.1506542112. Epub 2015 Dec 14.

4.

Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.

Zeglis BM, Davis CB, Abdel-Atti D, Carlin SD, Chen A, Aggeler R, Agnew BJ, Lewis JS.

Bioconjug Chem. 2014 Dec 17;25(12):2123-8. doi: 10.1021/bc500499h. Epub 2014 Nov 26.

5.

Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry.

Zeglis BM, Davis CB, Aggeler R, Kang HC, Chen A, Agnew BJ, Lewis JS.

Bioconjug Chem. 2013 Jun 19;24(6):1057-67. doi: 10.1021/bc400122c. Epub 2013 May 30.

6.

Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays.

Nadanaciva S, Bernal A, Aggeler R, Capaldi R, Will Y.

Toxicol In Vitro. 2007 Aug;21(5):902-11. Epub 2007 Jan 20.

PMID:
17346924
7.

Mass spectrometric identification of a novel phosphorylation site in subunit NDUFA10 of bovine mitochondrial complex I.

Schilling B, Aggeler R, Schulenberg B, Murray J, Row RH, Capaldi RA, Gibson BW.

FEBS Lett. 2005 Apr 25;579(11):2485-90.

8.

Focused proteomics: towards a high throughput monoclonal antibody-based resolution of proteins for diagnosis of mitochondrial diseases.

Murray J, Yonally S, Aggeler R, Marusich MF, Capaldi RA.

Biochim Biophys Acta. 2004 Dec 6;1659(2-3):206-11.

9.

Characterization of dynamic and steady-state protein phosphorylation using a fluorescent phosphoprotein gel stain and mass spectrometry.

Schulenberg B, Goodman TN, Aggeler R, Capaldi RA, Patton WF.

Electrophoresis. 2004 Aug;25(15):2526-32.

PMID:
15300772
11.

Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells.

Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington SJ, Capaldi RA.

Cancer Res. 2004 Feb 1;64(3):985-93.

12.

Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators.

Hanson GT, Aggeler R, Oglesbee D, Cannon M, Capaldi RA, Tsien RY, Remington SJ.

J Biol Chem. 2004 Mar 26;279(13):13044-53. Epub 2004 Jan 13.

13.

Analysis of steady-state protein phosphorylation in mitochondria using a novel fluorescent phosphosensor dye.

Schulenberg B, Aggeler R, Beechem JM, Capaldi RA, Patton WF.

J Biol Chem. 2003 Jul 18;278(29):27251-5. Epub 2003 May 20.

14.

A replicating module as the unit of mitochondrial structure and functioning.

Capaldi RA, Aggeler R, Gilkerson R, Hanson G, Knowles M, Marcus A, Margineantu D, Marusich M, Murray J, Oglesbee D, Remington SJ, Rossignol R.

Biochim Biophys Acta. 2002 Sep 10;1555(1-3):192-5.

15.

A functionally active human F1F0 ATPase can be purified by immunocapture from heart tissue and fibroblast cell lines. Subunit structure and activity studies.

Aggeler R, Coons J, Taylor SW, Ghosh SS, Garcia JJ, Capaldi RA, Marusich MF.

J Biol Chem. 2002 Sep 13;277(37):33906-12. Epub 2002 Jul 10.

16.

Mechanism of the F(1)F(0)-type ATP synthase, a biological rotary motor.

Capaldi RA, Aggeler R.

Trends Biochem Sci. 2002 Mar;27(3):154-60. Review.

PMID:
11893513
17.

Large conformational changes of the epsilon subunit in the bacterial F1F0 ATP synthase provide a ratchet action to regulate this rotary motor enzyme.

Tsunoda SP, Rodgers AJ, Aggeler R, Wilce MC, Yoshida M, Capaldi RA.

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6560-4. Epub 2001 May 29.

18.

Rotation of the c subunit oligomer in fully functional F1Fo ATP synthase.

Tsunoda SP, Aggeler R, Yoshida M, Capaldi RA.

Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):898-902. Epub 2001 Jan 23.

19.

Observations of rotation within the F(o)F(1)-ATP synthase: deciding between rotation of the F(o)c subunit ring and artifact.

Tsunoda SP, Aggeler R, Noji H, Kinosita K Jr, Yoshida M, Capaldi RA.

FEBS Lett. 2000 Mar 31;470(3):244-8.

20.

Cross-linking and electron microscopy studies of the structure and functioning of the Escherichia coli ATP synthase.

Capaldi RA, Schulenberg B, Murray J, Aggeler R.

J Exp Biol. 2000 Jan;203(Pt 1):29-33. Review.

22.

The second stalk: the delta-b subunit connection in ECF1F0.

Ogilvie I, Wilkens S, Rodgers AJ, Aggeler R, Capaldi RA.

Acta Physiol Scand Suppl. 1998 Aug;643:169-75. Review.

PMID:
9789558
24.

The subunit delta-subunit b domain of the Escherichia coli F1F0 ATPase. The B subunits interact with F1 as a dimer and through the delta subunit.

Rodgers AJ, Wilkens S, Aggeler R, Morris MB, Howitt SM, Capaldi RA.

J Biol Chem. 1997 Dec 5;272(49):31058-64.

27.

Structural changes in the gamma and epsilon subunits of the Escherichia coli F1F0-type ATPase during energy coupling.

Capaldi RA, Aggeler R, Wilkens S, Grüber G.

J Bioenerg Biomembr. 1996 Oct;28(5):397-401. Review.

PMID:
8951085
30.
33.

Coupling between catalytic sites and the proton channel in F1F0-type ATPases.

Capaldi RA, Aggeler R, Turina P, Wilkens S.

Trends Biochem Sci. 1994 Jul;19(7):284-9. Review.

PMID:
8048168
34.

TFPACD, a novel bifunctional reagent for reacting with DCCD sites in proteins: studies using Escherichia coli ATP synthase.

Phadke AS, Aggeler R, Keana JF, Capaldi RA.

Biochem Biophys Res Commun. 1994 Jun 15;201(2):635-41.

PMID:
8002996
39.
42.

Ligand-dependent structural variations in Escherichia coli F1 ATPase revealed by cryoelectron microscopy.

Gogol EP, Johnston E, Aggeler R, Capaldi RA.

Proc Natl Acad Sci U S A. 1990 Dec;87(24):9585-9.

43.

Monoclonal antibody modification of the ATPase activity of Escherichia coli F1 ATPase.

Aggeler R, Mendel-Hartvig J, Capaldi RA.

Biochemistry. 1990 Nov 13;29(45):10387-93.

PMID:
2148117
45.

Isolation and characterization of the cDNAs encoding two isoforms of subunit CIX of bovine cytochrome c oxidase.

Lightowlers R, Ewart G, Aggeler R, Zhang YZ, Calavetta L, Capaldi RA.

J Biol Chem. 1990 Feb 15;265(5):2677-81.

46.
47.

Reduced expression of outer-membrane proteins in beta-lactam-resistant mutants of Enterobacter cloacae.

Aggeler R, Then RL, Ghosh R.

J Gen Microbiol. 1987 Dec;133(12):3383-92.

PMID:
3503923
48.

Labeling of the ATP synthase of Escherichia coli from the head-group region of the lipid bilayer.

Aggeler R, Zhang YZ, Capaldi RA.

Biochemistry. 1987 Nov 3;26(22):7107-13.

PMID:
2892529
49.
50.

Supplemental Content

Loading ...
Support Center